77 related articles for article (PubMed ID: 27789675)
1. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Klemann C; Esquivel M; Magerus-Chatinet A; Lorenz MR; Fuchs I; Neveux N; Castelle M; Rohr J; da Cunha CB; Ebinger M; Kobbe R; Kremens B; Kollert F; Gambineri E; Lehmberg K; Seidel MG; Siepermann K; Voelker T; Schuster V; Goldacker S; Schwarz K; Speckmann C; Picard C; Fischer A; Rieux-Laucat F; Ehl S; Rensing-Ehl A; Neven B
Haematologica; 2017 Feb; 102(2):e52-e56. PubMed ID: 27789675
[No Abstract] [Full Text] [Related]
2. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract][Full Text] [Related]
3. Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection.
Nocerino A; Valencic E; Loganes C; Pelos G; Tommasini A
Pediatr Int; 2018 Mar; 60(3):315-317. PubMed ID: 29480551
[No Abstract] [Full Text] [Related]
4. Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly.
Sobh A; Crestani E; Cangemi B; Kane J; Chou J; Pai SY; Notarangelo LD; Al-Herz W; Geha RS; Massaad MJ
J Allergy Clin Immunol; 2016 Jan; 137(1):324-327.e2. PubMed ID: 26456038
[No Abstract] [Full Text] [Related]
5. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
[TBL] [Abstract][Full Text] [Related]
6. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability.
Marciano BE; Zerbe CS; Falcone EL; Ding L; DeRavin SS; Daub J; Kreuzburg S; Yockey L; Hunsberger S; Foruraghi L; Barnhart LA; Matharu K; Anderson V; Darnell DN; Frein C; Fink DL; Lau KP; Long Priel DA; Gallin JI; Malech HL; Uzel G; Freeman AF; Kuhns DB; Rosenzweig SD; Holland SM
J Allergy Clin Immunol; 2018 Jan; 141(1):365-371. PubMed ID: 28528201
[TBL] [Abstract][Full Text] [Related]
7. An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
Songdej D; Babbs C; Higgs DR;
Blood; 2017 Mar; 129(10):1251-1259. PubMed ID: 28057638
[TBL] [Abstract][Full Text] [Related]
8. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
9. Too much of a good thing: a review of primary immune regulatory disorders.
Tsilifis C; Slatter MA; Gennery AR
Front Immunol; 2023; 14():1279201. PubMed ID: 38022498
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome.
Jiang D; Rosenlind K; Baxter S; Gernsheimer T; Gulsuner S; Allenspach EJ; Keel SB
Blood Adv; 2023 Dec; 7(23):7202-7208. PubMed ID: 37792884
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation.
Toskov V; Ehl S
Mol Cell Pediatr; 2023 Sep; 10(1):11. PubMed ID: 37702894
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome (ALPS) due to a novel dominant negative germline mutation in the FAS gene.
Rodríguez-Bayona B; Lucena-Soto JM; Croché-Santander B; Olbrich P; González-Escribano MF; Neth O
Immunol Res; 2024 Feb; 72(1):162-166. PubMed ID: 37548830
[No Abstract] [Full Text] [Related]
14. Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous
Elgharbawy FM; Karim MY; Soliman DS; Hassan AS; Sudarsanan A; Gad A
Front Pediatr; 2023; 11():1150179. PubMed ID: 37152306
[TBL] [Abstract][Full Text] [Related]
15. Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features.
Gu H; Mou W; Chen Z; Xie X; Yao J; Zhang R; Wu R; Gui J
Front Pediatr; 2022; 10():1014249. PubMed ID: 36741091
[TBL] [Abstract][Full Text] [Related]
16. Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.
Batlle-Masó L; Garcia-Prat M; Parra-Martínez A; Franco-Jarava C; Aguiló-Cucurull A; Velasco P; Antolín M; Rivière JG; Martín-Nalda A; Soler-Palacín P; Martínez-Gallo M; Colobran R
Front Immunol; 2022; 13():1014984. PubMed ID: 36466883
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias.
Kumar D; Nguyen TH; Bennett CM; Prince C; Lucas L; Park S; Lawrence T; Chappelle K; Ishaq M; Waller EK; Prahalad S; Briones M; Chandrakasan S
Blood; 2023 Jan; 141(3):238-243. PubMed ID: 36206504
[TBL] [Abstract][Full Text] [Related]
18. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.
Schiavo E; Martini B; Attardi E; Consonni F; Ciullini Mannurita S; Coniglio ML; Tellini M; Chiocca E; Fotzi I; Luti L; D'Alba I; Veltroni M; Favre C; Gambineri E
Front Immunol; 2021; 12():790455. PubMed ID: 35058929
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease.
Yang K; Han J; Asada M; Gill JG; Park JY; Sathe MN; Gattineni J; Wright T; Wysocki CA; de la Morena MT; Garza LA; Yan N
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 35040435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
